Dapagliflozin, Glimepiride and Metformin Hydrochloride (Extended Release) Tablets MG1

Dapagliflozin, Glimepiride and Metformin Hydrochloride (Extended Release) Tablets MG1

MRP :- ₹ 310.00

Description
Dapagliflozin, Glimepiride and Metformin Hydrochloride (Extended Release) Tablets MG1 is a triple-combination antidiabetic medication containing DapagliflozinGlimepiride, and Metformin in an extended-release formulation. It is used to improve blood glucose control in adults with Type 2 Diabetes. The combination works through complementary mechanisms to help lower blood sugar levels, enhance insulin effectiveness, and support long-term diabetes management.

Dosage
Use as directed by the physician.

Indications

  • Management of Type 2 Diabetes Mellitus in adults

  • Improvement of glycemic control when diet and exercise alone are insufficient

  • Patients requiring combination therapy with Dapagliflozin, Glimepiride, and Metformin

  • Long-term diabetes management under medical supervision

Frequently Asked Questions

Find answers to the most common questions about our services.